| 000 | 01525 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515073128.0 | ||
| 264 | 0 | _c20080205 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0007-0963 | ||
| 024 | 7 |
_a10.1111/j.1365-2133.2007.08041.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aViguier, M | |
| 245 | 0 | 0 |
_aRemission of photosensitivity following treatment of psoriasis vulgaris with tumour necrosis factor inhibitors. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cSep 2007 |
||
| 300 |
_a625-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aPhotosensitivity Disorders _xprevention & control |
| 650 | 0 | 4 |
_aPsoriasis _xcomplications |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aJeanmougin, M | |
| 700 | 1 | _aBegon, E | |
| 700 | 1 | _aVerola, O | |
| 700 | 1 | _aDubertret, L | |
| 700 | 1 | _aBachelez, H | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 157 _gno. 3 _gp. 625-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2133.2007.08041.x _zAvailable from publisher's website |
| 999 |
_c17132862 _d17132862 |
||